Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 20:00
Amgen Price : 443.84 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 431.72 | 440.51 | 429.38 | 439.33 | 2.115M |
| Aug 20, 2026 | 435.78 | 441.34 | 431.07 | 433.73 | 2.914M |
| Aug 19, 2026 | 430.24 | 443.20 | 429.38 | 442.36 | 2.544M |
| Aug 18, 2026 | 421.64 | 427.39 | 420.72 | 425.28 | 2.592M |
| Aug 17, 2026 | 412.98 | 419.60 | 410.40 | 419.38 | 2.881M |
| Aug 14, 2026 | 413.76 | 416.03 | 410.50 | 415.21 | 2.037M |
| Aug 13, 2026 | 419.92 | 420.26 | 415.78 | 417.84 | 2.778M |
| Aug 12, 2026 | 413.31 | 418.19 | 409.00 | 416.18 | 2.066M |
| Aug 11, 2026 | 415.52 | 421.79 | 412.20 | 414.30 | 2.030M |
| Aug 10, 2026 | 408.46 | 417.36 | 406.42 | 417.20 | 1.960M |
| Aug 07, 2026 | 404.09 | 411.60 | 401.07 | 410.94 | 1.822M |
| Aug 06, 2026 | 413.72 | 418.40 | 401.20 | 404.85 | 2.609M |
| Aug 05, 2026 | 393.36 | 416.24 | 391.00 | 407.83 | 5.751M |
| Aug 04, 2026 | 380.76 | 390.92 | 376.02 | 390.02 | 3.623M |
| Aug 03, 2026 | 388.50 | 391.03 | 375.96 | 378.87 | 3.443M |
| Jul 31, 2026 | 382.00 | 386.82 | 379.34 | 385.16 | 1.955M |
| Jul 30, 2026 | 379.74 | 388.41 | 378.22 | 387.64 | 3.005M |
| Jul 29, 2026 | 395.03 | 397.88 | 386.58 | 387.64 | 3.005M |
| Jul 28, 2026 | 383.25 | 398.00 | 382.21 | 393.10 | 3.414M |
| Jul 27, 2026 | 378.55 | 382.28 | 374.40 | 376.26 | 2.903M |
| Jul 24, 2026 | 372.72 | 379.41 | 372.16 | 376.04 | 2.494M |
| Jul 23, 2026 | 359.98 | 371.84 | 359.21 | 371.50 | 2.932M |
| Jul 22, 2026 | 369.22 | 371.00 | 364.86 | 366.05 | 1.548M |
| Jul 21, 2026 | 365.08 | 368.91 | 362.14 | 366.24 | 2.882M |
| Jul 20, 2026 | 367.95 | 370.29 | 363.65 | 364.17 | 1.922M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 146.76 |
| Regeneron Pharmaceuticals, Inc. | 828.72 |
| AbbVie, Inc. | 264.49 |
| Biogen, Inc. | 218.11 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
Price Related Metrics
| PE Ratio | 27.57 |
| PS Ratio | 6.312 |
| PEG Ratio | 0.8696 |
| Price to Book Value | 20.53 |
| Price to Free Cash Flow | 23.70 |
| Earnings Yield | 3.63% |
| Market Cap | 239.94B |
| PEGY Ratio | 0.8117 |
| Operating PE Ratio | 18.95 |
| Normalized PE Ratio | 25.16 |